KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Revenue (2016 - 2025)

Historic Revenue for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.

  • Bausch Health Companies' Revenue rose 681.27% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 billion, marking a year-over-year increase of 585.81%. This contributed to the annual value of $9.6 billion for FY2024, which is 991.21% up from last year.
  • Bausch Health Companies' Revenue amounted to $2.7 billion in Q3 2025, which was up 681.27% from $2.5 billion recorded in Q2 2025.
  • Bausch Health Companies' 5-year Revenue high stood at $7.2 billion for Q4 2021, and its period low was $1.9 billion during Q1 2022.
  • Moreover, its 5-year median value for Revenue was $2.2 billion (2022), whereas its average is $2.5 billion.
  • Per our database at Business Quant, Bausch Health Companies' Revenue skyrocketed by 22715.77% in 2021 and then tumbled by 6970.99% in 2022.
  • Bausch Health Companies' Revenue (Quarter) stood at $7.2 billion in 2021, then tumbled by 69.71% to $2.2 billion in 2022, then grew by 9.8% to $2.4 billion in 2023, then increased by 6.27% to $2.6 billion in 2024, then increased by 4.77% to $2.7 billion in 2025.
  • Its Revenue stands at $2.7 billion for Q3 2025, versus $2.5 billion for Q2 2025 and $2.3 billion for Q1 2025.